Development of Water Transplant Based Single Core Osmotic Pump for Fluvoxamine Maleate Employing Quality by Design Principles
Abstract
The present study draw a bead on preparing single core osmotic pump with improved water transplant by employing Quality by Design (QbD) principles to achieve zero order drug release for prolonged period of time. QbD principles were employed in preparing single core osmotic pump by deriving quality target product profile (QTPP), critical quality attributes (CQA) followed by risk assessment using ishikawa diagram and risk estimation matrix. Box-Behnken Design was employed to study the effect of various independent parameters like concentration of Natrosol 250 HX (X1) and concentration of Xylitab (X2) no. of orifice (X3), on various dependent parameters like lag time (Y1) and time required for release 25%, 50%, 75% and 100% drug (Y2, Y3, Y4 and Y5). A controlled space was designed where each criteria or CQA was satisfied. Optimized formulation was further characterized for its efficiency. The results of design suggest the suitability of design for optimization of single core osmotic pump. In the initial period, drug release was driven by no. of orifice which on later stage depends on concentration of swellable polymer and concentration of osmogen. Optimized design was validated by preparing check point batch having less than 5% predicted error. Model fitting with drug release kinetics showed that optimized single core osmotic pump released drug in zero order. Stability data suggested that prepared formulation was stable for 3 month period without significant changes in the CQA. Single core osmotic pump using water transplant was successfully developed for a poorly soluble drug using QbD principles.
Keywords:
Zero order, Water transplant, Osmotic pump, QbDDOI
https://doi.org/10.25004/IJPSDR.2020.120114References
Thombre AG, Wu XY, am Ende MT. Chemical Engineering in the Pharmaceutical Industry: Active Pharmaceutical Ingredients, A John Wiley & Sons Publication, Second Edition, 2019;p381-407.
Bruck SD, editor. Controlled Drug Delivery: Volume 1 Basic Concepts. CRC Press; 2019 Jun 4.
Tomar A, Wadhwani S, Bhadauria RS. An overview on oral controlled release matrix Tablet. International Journal of Pharmaceutical Erudition. 2019;4:10-21.
Jahromi AK, Shieh H, Saadatmand M. Theoretical study of diffusional release of a dispersed solute from cylindrical polymeric matrix: A novel configuration for providing zero-order release profile. Applied Mathematical Modelling. 2019;73:136-145.
Malaterre V, Ogorka J, Loggia N, Gurny R. Approach to design push–pull osmotic pumps. International journal of pharmaceutics. 2009;376(1-2):56-62.
Theeuwes F. Elementary osmotic pump. Journal of pharmaceutical sciences. 1975;64(12):1987-1991.
Thombre AG, Appel LE, Chidlaw MB, Daugherity PD, Dumont F, Evans LA, Sutton SC. Osmotic drug delivery using swellable-core technology. Journal of Controlled Release. 2004;94(1):75-89.
Azharshekoufeh B L, Javadzadeh Y, Jalali MB, Nokhodchi A, Shokri J. Design and formulation of nano-porous controlled porosity osmotic pumps (CPOPs) containing a poorly water soluble drug, glibenclamide. Pakistan Journal of Pharmaceutical Sciences 2019;32(5):1979-1986.
Tyagi Y, Madhav NS. Smart innovative approach for designing fluvoxamine loaded bio-nanosuspension for the management of depression. International Journal of Applied Pharmceutics. 2019; 11(1):191-197.
Diva A A, Fathi S, Chekin F. Determination of Fluvoxamine in Real Samples using Carbon Paste Electrode Modified by Electrodeposition of Nickel. Journal of Analytical Chemistry. 2019; 74(8):809-815.
Xu X, Costa AP, Khan MA, Burgess DJ. Application of quality by design to formulation and processing of protein liposomes. International journal of pharmaceutics. 2012;434(1-2):349-359.
Rathod M, Suthar D, Patel H, Shelat P. Parejiya P. Microemulsion based nasal spray: A systemic approach for non-CNS drug, its optimization, characterization and statistical modelling using QbD principles. Journal of Drug Delivery Science and Technology. 2019;49:286-300.
Banerjee A, Verma PRP, Gore S. Application of Box–Behnken Design to Optimize the Osmotic Drug Delivery System of Metoprolol Succinate and its In-vivo E valuation in Beagle Dogs. Journal of Pharmaceutical Innovation. 2016;11(2):120-133.
Waterman KC, MacDonald BC, Roy MC. Extrudable core system: development of a single-layer osmotic controlled-release Tablet. Journal of Controlled Release. 2009;134(3):201-206.
Verma RK, Garg S. Development and evaluation of osmotically controlled oral drug delivery system of glipizide. European Journal of Pharmaceutics and Biopharmaceutics. 2004;57(3):513-525.
Cheng X, Sun M, Gao Y, Cao F, Zhai G. Design and evaluation of osmotic pump-based controlled release system of Ambroxol Hydrochloride. Pharm Dev Technol. 2011;16(4):392-399.
Parejiya PB, Barot BS, Patel HK, Shelat PK, Shukla A. Innovation of novel ‘Tab in Tab’system for release modulation of milnacipran HCl: optimization, formulation and in vitro investigations. Drug development and industrial pharmacy. 2013;39(11):1851-1863.
Published

